Merck ’s MRK stock has declined around 10.3% in the past three months, losing almost $32 billion of its market value.

“It’s one of the most important data sets on the early pandemic and on the origin of SARS-CoV-2,” says Florence Débarre, an ...

Charlie CY Yang, an analyst from Bank of America Securities, maintained the Buy rating on Merck & Company (MRK – Research Report).

Deep-pocketed investors have adopted a bullish approach towards Merck & Co MRK, and it's something market players shouldn't ...

Merck Animal Health recently awarded $90,000 in scholarships to nine aspiring bovine veterinarians in collaboration with the ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $144.12, a high estimate of $155 ...

Along with breast cancer, cervical cancer is among the most feared cancer diagnoses for women around the world.

We recently compiled a list of the 12 Best Blue Chip Stocks To Invest In According to Short Sellers. In this article, we are ...

Merck ( MRK 0.53%) stock has been a longtime winner for investors, returning 72% in the past five years. A major factor in ...

Its Animal Health segment also closed the acquisition of Elanco’s aqua business, presenting Merck & Co., Inc. (NYSE:MRK) as a leader in the animal health business. Overall, in the second quarter of ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

While economic data may be scarce, every data point gives a new angle to the ever-uncertain economic conditions in the US.